FDA NDC Directory · JSON-LD · Markdown

Avance Nerve Graft

NDC 84545-270 · HUMAN PRESCRIPTION DRUG · IMPLANT

Generic nameProcessed nerve allograft
Labeler / ManufacturerAxogen Corporation
Marketing categoryBiologic License Application · App BLA125816
Dosage form / routeIMPLANT · SOFT TISSUE
Active ingredientsHUMAN PERIPHERAL NERVE TISSUE (2 mm/70mm)
Marketing started20260406
Package count1

External sources

Source: openFDA. Public-domain (CC0).